1738 related articles for article (PubMed ID: 24048065)
21. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells and human malignant melanoma.
Schatton T; Frank MH
Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
[TBL] [Abstract][Full Text] [Related]
23. Evolution of cancer stem cells.
Bapat SA
Semin Cancer Biol; 2007 Jun; 17(3):204-13. PubMed ID: 16787749
[TBL] [Abstract][Full Text] [Related]
24. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
25. [Stem cell--is there any role in tumorigenic activity].
Saigal S; Bhargava A
Turk Patoloji Derg; 2011 May; 27(2):93-7. PubMed ID: 21630193
[TBL] [Abstract][Full Text] [Related]
26. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
[TBL] [Abstract][Full Text] [Related]
27. The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing.
Wood HM; Conway C; Daly C; Chalkley R; Berri S; Senguven B; Stead L; Ross L; Egan P; Chengot P; Graham J; Sethi N; Ong TK; High A; MacLennan K; Rabbitts P
J Pathol; 2015 Nov; 237(3):296-306. PubMed ID: 26096211
[TBL] [Abstract][Full Text] [Related]
28. New hypothesis on the origin of metastases.
Schischmanov N
Nagoya J Med Sci; 2013 Feb; 75(1-2):153-9. PubMed ID: 23544280
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic roles of EMT-inducing transcription factors.
Puisieux A; Brabletz T; Caramel J
Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells in tumor heterogeneity.
Pietras A
Adv Cancer Res; 2011; 112():255-81. PubMed ID: 21925307
[TBL] [Abstract][Full Text] [Related]
31. [Molecular origins of cancer and future cancer therapy].
Xie L; Hu WJ; Liu BR
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):81-84. PubMed ID: 29502365
[TBL] [Abstract][Full Text] [Related]
32. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
[TBL] [Abstract][Full Text] [Related]
33. Urothelial carcinoma: stem cells on the edge.
Brandt WD; Matsui W; Rosenberg JE; He X; Ling S; Schaeffer EM; Berman DM
Cancer Metastasis Rev; 2009 Dec; 28(3-4):291-304. PubMed ID: 20012172
[TBL] [Abstract][Full Text] [Related]
34. Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.
He K; Xu T; Goldkorn A
Mol Cancer Ther; 2011 Jun; 10(6):938-48. PubMed ID: 21518726
[TBL] [Abstract][Full Text] [Related]
35. Cancer germline gene activation: friend or foe?
McFarlane RJ; Feichtinger J; Larcombe L
Cell Cycle; 2014; 13(14):2151-2. PubMed ID: 25111983
[No Abstract] [Full Text] [Related]
36. Understanding cancer stem cell heterogeneity and plasticity.
Tang DG
Cell Res; 2012 Mar; 22(3):457-72. PubMed ID: 22357481
[TBL] [Abstract][Full Text] [Related]
37. [ADULT STEM CELLS AND CELLS OF MALIGNANT ORIGIN. PART II].
Sverdlov ED; Pleshkan VV; Alekseenko IV; Vinogradova TV; Kopantzev EP; Didich DA
Mol Gen Mikrobiol Virusol; 2015; 33(4):3-8. PubMed ID: 27192814
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in cancer: cancer stem cells versus clonal evolution.
Shackleton M; Quintana E; Fearon ER; Morrison SJ
Cell; 2009 Sep; 138(5):822-9. PubMed ID: 19737509
[TBL] [Abstract][Full Text] [Related]
39. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
[TBL] [Abstract][Full Text] [Related]
40. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.
Zhu L; Gibson P; Currle DS; Tong Y; Richardson RJ; Bayazitov IT; Poppleton H; Zakharenko S; Ellison DW; Gilbertson RJ
Nature; 2009 Jan; 457(7229):603-7. PubMed ID: 19092805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
